---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-037043"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T21:46:41.764157+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast Q3 revenue down 39.6% YoY to $235.9M; EPS $2.12 vs $3.27

## Summary
- Revenue $235.9M (-39.6% YoY); net income $23.1M (-36.2% YoY); diluted EPS $2.12 vs $3.27.
- Active earning Coaches 47,100 (-28.9% YoY); revenue per Coach $5,008 (-15.1%).
- FY2023 guidance: revenue $1,050M-1,070M; diluted EPS $8.65-$9.55.
- Cash & investments $157.8M, no debt; declared $1.65/share dividend payable Nov 7.

## SEC filing metadata
- accession: 0001628280-23-037043
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828023037043/0001628280-23-037043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828023037043/med-20231106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-037043
- JSON: https://secwatch.observer/filing/0001628280-23-037043.json
- Plain text: https://secwatch.observer/filing/0001628280-23-037043.txt

## Key facts
- Earnings Releases
  MEDIFAST INC reported third quarter ended September 30, 2023 results: revenue Revenue of $235.9 million, net income Net income of $23.1 million, EPS Earnings per diluted share ("EPS") of $2.12.
  - Period: third quarter ended September 30, 2023
  - Revenue: Revenue of $235.9 million
  - Net income: Net income of $23.1 million
  - EPS: Earnings per diluted share ("EPS") of $2.12
  - Result: reported results
  source text: Medifast Announces Third Quarter 2023 Financial Results November 6, 2023 BALTIMORE--(BUSINESS WIRE)-- Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA®, today reported results for the third quarter ended September 30, 2023. Third Quarter 2023 • Revenue of $235.9 million, with revenue per active earning Coach of $5,008 • Independent active earning OPTA VIA Coaches of 47,100 • Net income of $23.1 million • Earnings per diluted share ("EPS") of $2.12
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828023037043/0001628280-23-037043-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.